QDEL as of Nov 2 · 04:03 ET
QDELNasdaqIn Vitro & In Vivo Diagnostic Substances

QuidelOrtho Corp · Brief

Next report

1 day

Nov 3 · after closeconfirmedQ3 FY26

Expected move

Inputs

Implied vs realized

8 reportsHistory
3 of 6≥ implied
avg implied
±13.5%
avg realized
±15.4%
Nov 7 '24—▲+12.61%—
Feb 12 '25±12.3%▲+4.28%×0.35
May 7 '25±16.6%▲+41.04%×2.47
Aug 5 '25±10.5%▼−1.01%×0.10
Nov 5 '25±13.9%▼−22.32%×1.61
Feb 11 '26±11.5%▼−17.59%×1.53
Q1 FY26±16.4%▼−6.00%×0.37
Q2 FY26—▼−24.72%—
quarterimplied−45%0+45%realized×
Q2 FY26—▼−24.72%—
Q1 FY26±16.4%▼−6.00%×0.37
Feb '26±11.5%▼−17.59%×1.53
Nov '25±13.9%▼−22.32%×1.61
Aug '25±10.5%▼−1.01%×0.10
May '25±16.6%▲+41.04%×2.47
2 older reports
Feb '25±12.3%▲+4.28%×0.35
Nov '24—▲+12.61%—
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 3 report · confirmed

Bull2 of 3

244managers reporting a position in the latest quarterly filings13F · Jun 30 '26
4tracked funds holding QDELN-PORT · Aug 31 '26

Bear2 of 3

3 of 6recent reports where the move came in under the options implied rangeEarnings history
4 of 23of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26
AI captions · Oct 26 '26once per report · top 2 per case

Linked exposure

QDEL report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 20impliedImplied move: ±20.0% into Nov 3 earnings (Oct 20 close).Source
Oct 20report dateEarnings date confirmed: Nov 3, after close.Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.